Newsweek points to research showing patients can put lost weight back on quickly once they come off GLP-1 drugs.
Recap by typeshit. Post by @newsweek on Instagram.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
Emory's Angela Haynes-Ferere and Cedars-Sinai's Amanda Velazquez say plateaus are common and advise seeing a doctor rather than stopping the drug.
Crypto payments to Chinese vendors selling both peptides and fentanyl ingredients rose 32% to $37.3M in 2025, TRM says, with US buyers the largest identifiable source.
Loading…